lastest PR 4/28/14 SLNX
Solanbridge Group Inc. Provides an Update on Progress
April 28 2014
Houston ? Solanbridge Group Inc. (OTC: SLNX) reports on its progress and on ongoing developments. "We are happy with the progress of the discussion conducted under the MOU and we hope to sign a final contract by the end of the 30 day period outlined in the MOU,? declared Charles R. Shirley, Chairman of the Board and Managing Director of Solanbridge. There is a great demand for the available medical marijuana licenses in Nova Scotia, but Shirley stated, ?We realize that there will be many strong competitors in Nova Scotia, but we believe that with the progress we have made in our discussions with our potential partner and the solid background of people that we will be bringing on board we will have a competitive advantage.?
Solanbridge is also encouraged by the changing public opinion landscape in certain U.S. jurisdictions and the potential for legislative changes toward less regulation of medical marijuana and potentially recreational marijuana use in Alaska, Oregon, Rhode Island, and Nevada. Medical marijuana is legal in 20 states. There is a movement toward medical marijuana legalization in Florida and Maryland, two jurisdictions where Solanbridge has a physical presence.
The Company continues to pursue a commercial grower?s license in Province of Nova Scotia. Plans have been developed to hire a full-time staff member to administer the application process, acquire a building, equip the building with a state-of-the-art security system, and build out all aspects of a commercial medical marijuana grower?s production facility. The MOU signed by the Company on March 29, 2014 still plans to close on time.
On April 23, 2014, due to the commitment of Solanbridge to the medical marijuana industry, the Company has cancelled and retired 500 million common stock shares of SLNX. Those shares will be returned to the Company?s Treasury immediately. Concurrent with the announcement of the Company?s total share reduction, the Company emphasized that the long-term goal of the Company is to reduce the number of common stock shares by another 1 billion common stock shares over the next two months?for a total cancellation and retirement of 1.5 billion common stock shares.
Solanbridge has filed a Consent Agreement, signed by Green, and Board of Directors resolution, signed by Shirley, ratifying the Consent Agreement, with OTC Markets, Inc.
About Solanbridge Group Inc.
Solanbridge Group Inc. is based in Spring, Texas and is a diversified holding company looking to expand into the medical marijuana industry by developing a commercial grower?s license in the Province of Nova Scotia, Canada. Solanbridge's subsidiary, David's Steak and Seafood, in Melbourne Beach, Florida, is a classic, upscale steak house, which presents polished dining in an atmosphere of timeless elegance, offering guests the finest cuts of choice USDA meats, fresh seafood and much more.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact:
For further information, please contact:Charles R. Shirley
Solanbridge Group Inc
charles@solanbridgegroup.com
832.225.1372
Copyright © 2014 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases
Solanbridge Group Inc. Provides an Update on Progress
April 28 2014
Houston ? Solanbridge Group Inc. (OTC: SLNX) reports on its progress and on ongoing developments. "We are happy with the progress of the discussion conducted under the MOU and we hope to sign a final contract by the end of the 30 day period outlined in the MOU,? declared Charles R. Shirley, Chairman of the Board and Managing Director of Solanbridge. There is a great demand for the available medical marijuana licenses in Nova Scotia, but Shirley stated, ?We realize that there will be many strong competitors in Nova Scotia, but we believe that with the progress we have made in our discussions with our potential partner and the solid background of people that we will be bringing on board we will have a competitive advantage.?
Solanbridge is also encouraged by the changing public opinion landscape in certain U.S. jurisdictions and the potential for legislative changes toward less regulation of medical marijuana and potentially recreational marijuana use in Alaska, Oregon, Rhode Island, and Nevada. Medical marijuana is legal in 20 states. There is a movement toward medical marijuana legalization in Florida and Maryland, two jurisdictions where Solanbridge has a physical presence.
The Company continues to pursue a commercial grower?s license in Province of Nova Scotia. Plans have been developed to hire a full-time staff member to administer the application process, acquire a building, equip the building with a state-of-the-art security system, and build out all aspects of a commercial medical marijuana grower?s production facility. The MOU signed by the Company on March 29, 2014 still plans to close on time.
On April 23, 2014, due to the commitment of Solanbridge to the medical marijuana industry, the Company has cancelled and retired 500 million common stock shares of SLNX. Those shares will be returned to the Company?s Treasury immediately. Concurrent with the announcement of the Company?s total share reduction, the Company emphasized that the long-term goal of the Company is to reduce the number of common stock shares by another 1 billion common stock shares over the next two months?for a total cancellation and retirement of 1.5 billion common stock shares.
Solanbridge has filed a Consent Agreement, signed by Green, and Board of Directors resolution, signed by Shirley, ratifying the Consent Agreement, with OTC Markets, Inc.
About Solanbridge Group Inc.
Solanbridge Group Inc. is based in Spring, Texas and is a diversified holding company looking to expand into the medical marijuana industry by developing a commercial grower?s license in the Province of Nova Scotia, Canada. Solanbridge's subsidiary, David's Steak and Seafood, in Melbourne Beach, Florida, is a classic, upscale steak house, which presents polished dining in an atmosphere of timeless elegance, offering guests the finest cuts of choice USDA meats, fresh seafood and much more.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact:
For further information, please contact:Charles R. Shirley
Solanbridge Group Inc
charles@solanbridgegroup.com
832.225.1372
Copyright © 2014 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases
